Charter Research & Investment Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$2.5M Buy
32,146
+450
+1% +$36.4K 2.93% 9
2016
Q2
$2.47M Sell
31,696
-205
-0.6% -$16.3K 2.83% 9
2016
Q1
$2.61M Sell
31,901
-990
-3% -$80.5K 3% 9
2015
Q4
$2.94M Sell
32,891
-125
-0.4% -$10.6K 3.41% 7
2015
Q3
$2.54M Buy
33,016
+80
+0.2% +$6.68K 3.35% 9
2015
Q2
$2.75M Sell
32,936
-190
-0.6% -$16.8K 3.06% 9
2015
Q1
$2.99M Sell
33,126
-25
-0.1% -$2.15K 3.31% 6
2014
Q4
$2.68M Buy
+33,151
New +$2.62M 2.93% 10

Other funds holding CAH

Charter Research & Investment Group's CAH Position: Q3 2016 in Review

Charter Research & Investment Group increased its Cardinal Health (CAH) stake by 1.4% in Q3 2016, buying an estimated $36.4K and bringing the position to 32,146 shares worth $2.5M. The position accounts for 2.93% of the portfolio, ranked #9.

Charter Research & Investment Group first reported a position in CAH in Q4 2014 and has held it in 8 quarters since. The position peaked at $2.99M in Q1 2015. 772 funds tracked by Wall St. Rank hold CAH as of Q3 2016.

  • Charter Research & Investment Group held 32,146 shares of Cardinal Health worth $2.5M as of Q3 2016.
  • Charter Research & Investment Group bought 450 Cardinal Health shares in Q3 2016, an estimated $36.4K.
  • Cardinal Health made up 2.93% of Charter Research & Investment Group's portfolio in Q3 2016, its #9 holding.
  • Charter Research & Investment Group first reported a position in Cardinal Health in Q4 2014 and has held it in 8 quarters since.
  • Charter Research & Investment Group's Cardinal Health position peaked at $2.99M in Q1 2015.
  • 772 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2016.

Based on Charter Research & Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.